Biotin Molecules
ID: W911S225U0221Type: Combined Synopsis/Solicitation
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW6QM MICC-FT DRUMFORT DRUM, NY, 13602-5220, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/5217a56e0bd242ff90d3aa04bc4aa397/view
Timeline
    Description

    The Department of Defense, specifically the Department of the Army, is seeking suppliers for various biotin molecules through a combined synopsis/solicitation. The procurement includes specific biotin products such as B-100-B a-Bungarotoxin-Biotin, STC-460-B Chlorotoxin-Biotin, STS-400-B Stichodactyla Toxin-Biotin, and STC-666-B Conantokin G-Biotin, each in 50ug quantities. These biotin molecules are essential for various analytical and laboratory applications, contributing to research and development in biochemical fields. Interested vendors can reach out to Carl Lundell at carl.lundell@westpoint.edu or call 845.938.8298 for further details regarding the procurement process.

    Point(s) of Contact
    Carl Lundell
    (845) 938-8298
    carl.lundell@westpoint.edu
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Biotin Molecules
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Allergen Extract Market Research
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking information from manufacturers and distributors regarding allergen extracts as part of a sources sought notice. The objective is to gain insights into the market for these extracts, particularly identifying which products respondents manufacture or distribute, and to encourage the submission of any unique FDA licenses or patents related to the desired allergen extracts listed in the accompanying document. This initiative is crucial for supporting research and diagnostic applications in public health, as the detailed listing of biological materials includes various concentrations and formulations relevant for scientific study. Interested parties should reach out to Jessie G. Hart at jessie.g.hart.civ@health.mil or Ricardo Cordero Cruz at ricardo.a.corderocruz.civ@health.mil for further information, with a future solicitation expected to be announced on sam.gov.
    Microbial Testing Supplies - Bridge Contract
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense (DoD) is seeking quotes for a Blanket Purchase Agreement (BPA) and Additional Discount Program (ADP) related to the procurement of pharmaceutical agents as part of its Uniform Formulary (UF) initiative. This procurement aims to establish an effective and integrated pharmacy benefits program for the Military Health System (MHS), focusing on the clinical and cost-effectiveness of newly approved drugs, including neurological agents, antibiotics, oncological agents, and various other pharmaceutical categories. Interested manufacturers must submit their quotes by January 16, 2025, with a pre-quotation teleconference scheduled for January 8, 2025, to discuss the requirements and expectations. For further inquiries, manufacturers can contact Tracy Banks at tracy.e.banks2.civ@health.mil or Patricia Tyson at patricia.a.tyson3.ctr@health.mil.
    POLYBUTADIENE
    Active
    Dept Of Defense
    The Department of Defense, specifically the Army Contracting Command – Rock Island, is soliciting proposals for the procurement of Polybutadiene, a liquid hydroxyl-terminated type, under Solicitation Number W519TC25Q2013. This procurement is set aside for 100% Small Business participation and aims to secure a Firm-Fixed-Price Purchase Order for a total quantity of 196,800 pounds, to be delivered in five shipments according to specified schedules. The Polybutadiene is essential for defense applications, adhering to Weapon Specification WS 23148D and MIL-DTL-82886A, ensuring compliance with safety and operational standards. Interested vendors must submit their proposals electronically by January 8, 2025, and are encouraged to direct any questions to Mike Perez at michael.e.perez24.civ@army.mil, while ensuring active registration in the System for Award Management (SAM) for eligibility.
    Microplate Reader
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking proposals for the procurement of a Microplate Reader through a Combined Synopsis/Solicitation notice. The required system must feature a low noise PMT detector for both fluorescence and luminescence modes, and it should be capable of measuring a full absorbance spectrum from 220 to 1000 nm at selectable resolutions, along with the ability to conduct measurements at multiple wavelengths simultaneously. This equipment is crucial for analytical laboratory functions, and the procurement includes installation, training, and a one-year manufacturer warranty, with delivery to West Point, NY. Interested vendors can reach out to Carl Lundell at carl.lundell@westpoint.edu or call 845.938.8298 for further details.
    Bicalutamide 50MG tablets
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) is issuing a solicitation for a national requirements contract for Bicalutamide 50MG tablets, available in bottle counts of 30 and 500. The procurement aims to establish a reliable supply source for these pharmaceutical items, which are critical for various Department of Defense and other federal health programs, including the Department of Veterans Affairs and the Indian Health Service. This unrestricted and fully competitive acquisition will be a firm-fixed price contract with a one-year base and four one-year options, with proposals due by January 24, 2025. Interested parties can reach out to Keith Ryales at keith.ryales@dla.mil or 215-737-9199 for further inquiries and are encouraged to monitor the DLA Bid Board System and SAM.gov for updates on the solicitation.
    Doxycycline Hyclate Solicitation
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting proposals for the procurement of Doxycycline Hyclate tablets under solicitation number SPE2D2-25-R-0004. This procurement aims to secure pharmaceutical products in various quantities and packaging configurations, with specific requirements outlined for compliance with federal regulations, including business ethics and subcontracting plans. Doxycycline Hyclate is a critical antibiotic used in various medical applications, making this procurement essential for maintaining adequate supplies for military and healthcare operations. Interested contractors must submit their proposals electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS) by January 21, 2025, and are encouraged to contact Courtney Hunter-Stangler or Jason C. Wray for further information regarding the solicitation.
    Doxycycline Hyclate
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Doxycycline Hyclate. The contract will establish a national supply source to provide Doxycycline Hyclate 100MG Tablets in various bottle sizes. This acquisition is for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be firm-fixed price, requirements type with a one year base and four one year options. Interested parties should contact Catherine Gilbert for more information. The projected solicitation date is September 2019.
    REQUEST FOR INFORMATION METABOLOMICS ANALYSIS SERVICES
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking information from qualified vendors for specialized metabolomics analysis services to support ongoing research at the United States Army Medical Research Institute of Environmental Medicine (USARIEM). The procurement aims to obtain both untargeted and targeted metabolomics measurements from various human biological samples, including urine, blood, feces, saliva, and tissue, necessitating advanced laboratory capabilities such as ultra-high performance liquid chromatography-tandem-mass spectrometry (UPLC-MS/MS) and gas chromatography-mass spectrometry (GC-MS). This initiative is critical for enhancing the understanding of metabolic functions and nutritional status within military health studies. Interested parties must submit their qualifications, including business size and capabilities, by January 7, 2025, to Kasey Carroll at kasey.l.carroll.civ@health.mil, as responses are voluntary and will not result in a binding contract.
    Bulk Pharma Group B
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) is seeking proposals for the procurement of a range of FDA-approved pharmaceuticals as part of the Bulk Pharma Group B initiative. The contract will require the delivery of specific injectable medications, including Acyclovir Sodium, Doxycycline, Levophed, Meropenem, Sodium Chloride, and sterile water, with quantities detailed in the attached Request for Proposal (RFP). This procurement is critical for maintaining the Strategic National Stockpile, ensuring a reliable supply of essential pharmaceuticals for disaster preparedness and response efforts. Interested vendors must submit their proposals by the specified deadline, and inquiries can be directed to primary contact Terri Reed at terri.reed@hhs.gov or secondary contact Kimberly Golden at kimberly.golden1@hhs.gov.